Gotham Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Gotham Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,085	Closed	-$235K	–	1289
2019 Q4	$235K	Sell	5,085 -5,416	-52%	-$235K	﹤0.01%	1007
2019 Q3	$428K	Buy	10,501 +3,086	+42%	+$133K	0.01%	812
2019 Q2	$357K	Buy	7,415 +3,160	+74%	+$166K	0.01%	892
2019 Q1	$266K	Sell	4,255 -12,591	-75%	-$865K	﹤0.01%	1031
2018 Q4	$1.01M	Buy	+16,846	New	+$1.01M	0.02%	631
2018 Q3	–	Sell	-16,251	Closed	-$731K	–	1076
2018 Q2	$731K	Sell	16,251 -5,727	-26%	-$228K	0.01%	630
2018 Q1	$682K	Buy	+21,978	New	+$723K	0.01%	672
2017 Q4	–	Sell	-19,730	Closed	-$651K	–	1134
2017 Q3	$651K	Buy	+19,730	New	+$683K	0.01%	669
2016 Q4	–	Sell	-26,153	Closed	-$486K	–	1135
2016 Q3	$486K	Buy	26,153 +7,783	+42%	+$147K	0.01%	715
2016 Q2	$299K	Buy	+18,370	New	+$270K	﹤0.01%	813

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gotham Asset Management's BEAT Position: Q1 2020 in Review

Gotham Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 5,085 shares — an estimated $235K sold.

Gotham Asset Management first reported a position in BEAT in Q2 2016 and held it in 10 quarters. The position peaked at $1.01M in Q4 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Gotham Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Gotham Asset Management sold 5,085 BioTelemetry, Inc. shares in Q1 2020, an estimated $235K.
Gotham Asset Management first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 10 quarters.
Gotham Asset Management's BioTelemetry, Inc. position peaked at $1.01M in Q4 2018.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.